NEW YORK (TheStreet) -- Goldman Sachs upgraded NuVasive  (NUVA) - Get Report to "buy" and set a $43 price target. The firm said discrete P&L items and natural operating leverage can drive EBIT margin expansion.

The stock closed at $34.82 on Wednesday.

Must Read: Warren Buffett's 25 Favorite Stocks

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Image placeholder title

NUVA data by YCharts

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.